GLO1 and pancreatic neuroendocrine tumor: Two patients with pancreatic NET were excluded from survival and progression analyses due to early death after surgical intervention; one patient had a high GLO1 copy number in primary tissue (4.13) and one had a low GLO1 copy number (0.91).